You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

central thrombocytopenia

Showing 1 - 25 of 9,458
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of Severe Fever With Thrombocytopenia Syndrome

Recruiting
  • Severe Fever With Thrombocytopenia Syndrome
    • Guangshui, Hubei, China
    • +7 more
    Aug 21, 2023

    Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Herombopag
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 24, 2023

    Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Avatrombopag
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 24, 2023

    Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)

    Recruiting
    • Chemotherapy-induced Thrombocytopenia
    • Eltrombopag
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 24, 2023

    Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)

    Recruiting
    • Severe Fever With Thrombocytopenia Syndrome
    • Guangshui, Hubei, China
    • +9 more
    Oct 31, 2022

    Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)

    Not yet recruiting
    • Connective Tissue Diseases
    • Thrombocytopenia
    • Telitacicept
    • Placebo
    • Hefei, Anhui, China
    • +21 more
    Aug 18, 2023

    Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)

    Completed
    • Thrombocytopenia Purpura
    • Chronic HBV Infection
    • Tianjin, Tianjin, China
      Ethics Committee of Blood disease hospital, Chinese Academy of M
    Jan 24, 2023

    Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

    Not yet recruiting
    • Chronic Primary Immune Thrombocytopenia (ITP)
    • Bengbu, Anhui, China
    • +13 more
    Aug 15, 2023

    Primary Immune Thrombocytopenia Trial in China (Orelabrutinib( lower dose), Orelabrutinib( higher dose))

    Recruiting
    • Primary Immune Thrombocytopenia
    • Orelabrutinib( lower dose)
    • Orelabrutinib( higher dose)
    • HaiKou, Hainan, China
    • +8 more
    Jan 10, 2023

    Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

    Not yet recruiting
    • Hematologic Neoplasms
    • +5 more
    • umbilical cord derived mesenchymal stem cells
    • Wuhan, Hubei, China
    • +2 more
    Jan 3, 2023

    Previously Treated Primary Immune Thrombocytopenia Trial in China (rhTPO, Eltrombopag)

    Recruiting
    • Previously Treated Primary Immune Thrombocytopenia
    • Guangzhou, Guangdong, China
    • +15 more
    Jan 24, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Immune Thrombocytopenia Trial in Worldwide (Rilzabrutinib, Placebo)

    Recruiting
    • Immune Thrombocytopenia
    • Los Angeles, California
    • +128 more
    Nov 3, 2022

    Primary Immune Thrombocytopenia Trial in Wuhan (rhTPO, eltrombopag)

    Unknown status
    • Primary Immune Thrombocytopenia
    • Wuhan, Hubei, China
      Zhou Yiming
    Nov 14, 2019

    Severe Malaria, Thrombocytopenia Trial in Baltimore, Ndola (Whole blood transfusion)

    Not yet recruiting
    • Severe Malaria
    • Thrombocytopenia
    • Whole blood transfusion
    • Baltimore, Maryland
    • +1 more
    Jan 25, 2023

    Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

    Recruiting
    • Antiphospholipid Syndrome
    • Thrombocytopenia
    • Anti-CD38 antibody Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)

    Completed
    • Non-Hodgkin Lymphoma
    • Milano, Italy
      Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
    Aug 10, 2022

    Heparin-induced Thrombocytopenia in Post-operative Cardiac

    Recruiting
    • Heparin-induced Thrombocytopenia
    • Post screening diagnostic test
    • Vandœuvre-lès-Nancy, Meurthe Et Moselle, France
      'CHRU Nancy
    Mar 23, 2023

    Platelets Sialylation by Flow Cytometry for Differential

    Completed
    • Idiopathic Thrombocytopenic Purpura
    • non interventional study
    • Nantes, France
      Nantes University Hospital
    Jan 17, 2022

    Bleeding Disorder, Stroke, Ischemic, Stroke Hemorrhagic Trial in Worldwide (XIENCE, DAPT)

    Completed
    Has Results
    • Bleeding Disorder
    • +8 more
    • Linz, Upr Aus, Austria
    • +51 more
    Feb 9, 2021

    Some Cytokines Expression in ITP Primary Immune Thrombocytopenic

    Recruiting
    • Primary Immune Thrombocytopenia
    • Plasma RNA isolation, qPCR analysis of micro RNA
    • +2 more
    • Sohag, Egypt
      Sohag University
    May 7, 2022

    Venous Thromboembolism Trial (Fondaparinux, Enoxaparin)

    Terminated
    • Venous Thromboembolism
    • (no location specified)
    Apr 7, 2022

    Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • (no location specified)
    Jun 5, 2023

    Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

    Active, not recruiting
    • Ovarian Cancer
    • +3 more
    • Duarte, California
    • +6 more
    Jan 21, 2023

    Cancer Trial (Cyanoacrylate glue application)

    Not yet recruiting
    • Cancer
    • Cyanoacrylate glue application
    • (no location specified)
    Jul 17, 2023